Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-10-23

FDA Approved: OXYBUTYNIN CHLORIDE — Original Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved ANI Pharmaceuticals' Original Application for oxybutynin chloride as a generic product for overactive bladder and related urinary incontinence symp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxybutynin chloride (Oxybutynin chloride)

Snippet

ORIG AP for OXYBUTYNIN CHLORIDE (OXYBUTYNIN CHLORIDE)